European lawmakers have held far more meetings with tobacco and nicotine lobbyists in the past two years than in the whole previous parliamentary term, according to data collected by the Smoke Free Partnership from the Transparency Register. Since this Parliament took office in the summer of 2024, more than 400 meetings have been declared, compared with about 100 in the 2019–2024 term. Lawmakers are required to disclose meetings on the register.

Most of the contacts this term were with right-leaning MEPs: roughly 75% involved members of the centre-right European People’s Party, the conservative European Conservatives and Reformists and the Patriots for Europe group. The uptick in meetings comes as the EU looks to overhaul several tobacco- and nicotine-related laws and proposes measures aimed at reducing heart disease and cancer that will touch the sector.

Some MEPs have warned about the industry’s access to lawmakers while health files are negotiated, including a cardiovascular disease strategy and a cancer plan. “I find it scandalous and shocking that there are more meetings with the tobacco industry than the NGOs and the associations that advocate for stop smoking,” said Tilly Metz of the Greens/European Free Alliance.

“When you are working on health files, it is completely incompatible to regularly meet with the tobacco industry,” she said, invoking the World Health Organization’s tobacco control treaty, which advises that policymakers should meet industry only when strictly necessary to discuss regulation.

The tobacco industry and MEPs who meet it regularly insist they have done nothing wrong. British American Tobacco’s head of fiscal affairs, Simon Trussler, said the company — like any other business in Europe — has legitimate experience and arguments to present “because we see what’s going on on the ground.”

Philip Morris International, which declared more meetings than any other tobacco company, pointed to its economic contribution and described itself as “undergoing a deep transformation towards a smoke-free future.” The company said it engages with any MEP willing to discuss “on the basis of science and facts” and stressed it also markets nicotine pouches, vapes and heated tobacco products.

Global treaty debate

A key concern raised by Metz and other MEPs is whether WHO tobacco control rules are being respected. The WHO Framework Convention on Tobacco Control stipulates that public health policies should be protected from commercial interests. Its implementation guidelines say policymakers should limit interactions with the industry to what is strictly necessary for regulation, and ensure transparency.

The industry argues it operates within the rules and points to a 2022 European Court of Justice judgment saying the treaty does not prohibit industry participation in implementing tobacco control and is intended to prevent the industry from influencing parties’ tobacco-control policies.

Industry also contends the WHO framework does not cover tobacco-free nicotine products — precisely the products most likely to face tougher controls as the EU updates rules on tobacco products, advertising and minimum taxes.

BAT’s Trussler said the company complies with regulations and that the WHO framework has been “misquoted and misunderstood.” The company argues the treaty’s scope is limited to products made from tobacco leaf.

WHO Europe, however, takes a broader view. Kristina Mauer-Stender, WHO Europe’s regional adviser on tobacco control, noted the treaty’s objective extends beyond reducing tobacco consumption: Article 5.2(b) calls for measures “for preventing and reducing tobacco consumption, nicotine addiction and exposure to tobacco smoke,” making prevention of nicotine addiction an explicit objective. The Conference of the Parties has increasingly addressed novel and emerging tobacco and nicotine products, she added.

Clusters

Critics say meetings cluster around key policy initiatives. The European People’s Party faced criticism this summer for softening language in a non-binding cardiovascular disease report regarding nicotine and tobacco rules, replacing wording that equated nicotine with tobacco regulation with a call for “appropriate rules.” Two MEPs who were among those meeting industry most often — Jessica Polfjärd and Elena Nevado del Campo — supported the change. The final report adopted by the Parliament reflected that proposal.

Romana Jerković, the Socialists and Democrats MEP who led the health committee report, said she had wished it could have been more ambitious on tobacco.

Lobbying activity has also intensified as the European Commission prepares to release updated regulations on tobacco and nicotine products. The Smoke Free Partnership says spikes in meetings cluster around policy initiatives such as the tax directive and that while meetings alone do not prove direct influence, they show the industry’s opportunities to shape the debate. Its director, Erin Roman, added that transparency around industry meetings is insufficient and that contacts should be “strictly necessary for effective regulation.”

Spain’s Nicolás González Casares, another Socialists and Democrats MEP, warned that amendments weakening rules on new tobacco products “didn’t come from nowhere: the groups meeting the industry most are the ones watering down the rules.”

MEPs who met industry most frequently this term mostly come from the right. Patriots MEP Auke Zijlstra declared the most meetings (14), followed by ECR’s Pietro Fiocchi with nine. EPP members Michalis Hadjipantela, Elena Nevado del Campo and Jessica Polfjärd each declared eight.

Zijlstra said he speaks with any industry affected by legislation and does not consider his number of meetings excessive. “Taking an interest in the field is an absolute part of the job,” he said, adding that many consumers also deserve to be heard and urging NGOs to ask for more meetings.

The Smoke Free Partnership said it faced “significant pressure” on resources after the withdrawal of some EU operating grants last year, forcing difficult choices about priorities and contributing to an imbalance with the industry’s resources.

A spokesperson for Hadjipantela said he engages with a broad range of stakeholders as a member of six committees and “remains fully independent in his assessments and decisions,” noting that meeting a stakeholder is not an endorsement of their views.

Nevado del Campo said her meetings with tobacco representatives reflected the importance of tobacco producers in her region and her duty to listen to a sector that employs many people; she also met groups on the opposing side of the debate and said her commitment is to both a healthy Europe and to farmers who boost the regional economy.

Fiocchi and Polfjärd did not respond to requests for comment by publication.

Topics and countries

Many meetings focused on the tobacco taxation directive, which would set minimum taxes on nicotine and tobacco products and expand what is covered. Other declared topics included tobacco products and advertising directives and debate around “harm reduction.” The Commission is drafting revisions to products and advertising rules.

Lawmakers declared at least 178 meetings with Philip Morris International representatives — more than any other manufacturer — and 60 with British American Tobacco.

Further data from Transparency International EU shows PMI ranked among the companies meeting the most MEPs and their assistants, alongside major digital firms. The Transparency Register dataset also highlights national differences: MEPs from Italy — a leading tobacco leaf producer — declared far more meetings with the industry than other nationalities, with around one in five declared meetings involving an Italian lawmaker. This was partly driven by Italian company Manifatture Sigaro Toscano meeting mainly with Italian MEPs; almost half of BAT’s meetings were with Italian lawmakers.

The dataset, which relies on lawmakers’ own declarations, probably underestimates the true scale of lobbying. Declarations with insufficient information were removed from the analysis, and newly declared meetings were added when located.

Large tobacco companies are working to migrate consumers onto nicotine products under a “harm reduction” narrative, arguing that nicotine and smoke-free products can be better alternatives to cigarettes. Critics dispute that argument, warning that people should not be exposed to addictive products and pointing to high use of nicotine pouches and similar products among young people who otherwise were not smokers.

At least 28 meetings in the dataset referenced public health measures rather than taxation or tobacco regulation, though many self-declared descriptions remain vague. Two meetings explicitly mentioned cardiovascular diseases.

Greens MEP Metz joined a group of lawmakers who pushed to restrict tobacco lobbyists’ access to EU lawmakers and accused the Parliament of failing to live up to obligations under the WHO treaty, but that push failed earlier this year. Metz said she will “continue to fight” for Parliament to fully respect the framework controlling tobacco.